Spain, Sept. 9 -- Spain based RECORDATI RARE DISEASES SPAIN S.L.U. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical Products - SUMENTITOR de Dinuximab beta (DOE). The value of the contract is worth 253822450 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....